Chargement en cours...
Antigen specificity can be irrelevant to immunocytokine efficacy and biodistribution
Cytokine therapy can activate potent, sustained antitumor responses, but collateral toxicity often limits dosages. Although antibody–cytokine fusions (immunocytokines) have been designed with the intent to localize cytokine activity, systemic dose-limiting side effects are not fully ameliorated by a...
Enregistré dans:
| Publié dans: | Proc Natl Acad Sci U S A |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
National Academy of Sciences
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4371941/ https://ncbi.nlm.nih.gov/pubmed/25733854 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1416159112 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|